Coherus BioSciences Inc reports results for the quarter ended in March - Earnings Summary

Coherus Oncology

09/05/2024 22:51

* Coherus BioSciences Inc  CHRS.OQ  reported a quarterly
adjusted
loss of 32 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of -75 cents.  The mean expectation of six analysts
for the quarter was for a loss of 24 cents per share. Wall
Street expected results to range from -37 cents to -5 cents per
share.
    * Revenue rose 137.6% to $77.06 million from a year ago;
analysts
expected $80.25 million. 
    * Coherus BioSciences Inc's reported EPS for the quarter was
83
cents​.
    * The company reported quarterly net income of $102.88
million.
    * Coherus BioSciences Inc shares had fallen by 6.7% this
quarter and lost 33.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 5.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Coherus
BioSciences Inc is $9.00 
This summary was machine generated from LSEG data May 9 at 09:50
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.24          -0.32          Missed
 Dec. 31 2023      -0.12          -0.62          Missed
 Sep. 30 2023      -0.27          -0.27          Met
 Jun. 30 2023      -0.48          -0.38          Beat